Suggestions
Idioma
Journal Information
Issue
Cover Vol. 45. Issue  S3. Vol. 45. Issue S3.
XIV Eurasian Hematology Oncology Congress
Pages S1-S48 (October 2023)
FM1 XIV Eurasian Hematology Oncology
Hematol Transfus Cell Ther. 2023;45 Supl 3:i
Full text access
PEDIATRIC PRESENTATIONS
Hematol Transfus Cell Ther. 2023;45 Supl 3:
Full text access
ORAL PRESENTATIONS
Hematol Transfus Cell Ther. 2023;45 Supl 3:
Full text access
POSTER PRESENTATIONS
Hematol Transfus Cell Ther. 2023;45 Supl 3:
Full text access
ADULT SPEAKER PRESENTATIONS
Hematol Transfus Cell Ther. 2023;45 Supl 3:
Full text access
FM2 Welcome address
Hematol Transfus Cell Ther. 2023;45 Supl 3:ii-vi
Full text access
FM3 Biographies
Hematol Transfus Cell Ther. 2023;45 Supl 3:vii-xiii
Full text access
Adult speaker presentations
Induction therapy choices and responses in a third world country: A single center study from Pakistan
Amjad Zafar, Parnia Ansari, Rishma Nadeem, Iqra Majeed, Mobeen Ud din, Fareeha Sheikh, Kausar Bano
Hematol Transfus Cell Ther. 2023;45 Supl 3:S1
Full text access
Bone marrow transplantation versus chimeric antigen receptor T cells (CAR-T) therapy for hematological malignancies
Arnon Nagler, on behalf of the Sheba Team
Hematol Transfus Cell Ther. 2023;45 Supl 3:S1-S2
Full text access
The revolution in frontline treatment of Multiple Myeloma
Claudio Cerchione
Hematol Transfus Cell Ther. 2023;45 Supl 3:S2
Full text access
CML 2023 - State Of The Art And Cutting Edge İssues
Pia Raanani
Hematol Transfus Cell Ther. 2023;45 Supl 3:S3
Full text access
Management Of Early Relapsed Follicular Lymphoma Debate Favoring Non-Transplant Options
Murat Özbalak
Hematol Transfus Cell Ther. 2023;45 Supl 3:S3
Full text access
Treatment Of Classical Hodgkin Lymphoma: The State Of The Art
Carmino Antonio de Souza, Guilherme Duffles
Hematol Transfus Cell Ther. 2023;45 Supl 3:S4
Full text access
MDS 2023: State of The Art
Moshe Mittelman
Hematol Transfus Cell Ther. 2023;45 Supl 3:S4-S5
Full text access
Blastic Plasmacytoid Dendritic Cell Neoplasm BPDCN
Hanan Hamed
Hematol Transfus Cell Ther. 2023;45 Supl 3:S5
Full text access
Personalized Dendritic Cell Vaccines
Anzhelika Alexandrovna Melnikova, Lyudmila Yurievna Grivtsova
Hematol Transfus Cell Ther. 2023;45 Supl 3:S6
Full text access
CPi -Clalit Proactive and Preventative Intervention
Doron Netzer
Hematol Transfus Cell Ther. 2023;45 Supl 3:S6-S7
Full text access
Pediatric presentations
HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN WITH CENTRAL NERVOUS SYSTEM TUMORS
Nurşah Eker
Hematol Transfus Cell Ther. 2023;45 Supl 3:S8
Full text access
STEM CELL TRANSPLANTATION AS A TREATMENT OPTION FOR RELAPSED/REFRACTORY GERM CELL TUMORS
Başak Adaklı Aksoy
Hematol Transfus Cell Ther. 2023;45 Supl 3:S8-S9
Full text access
CURRENT THERAPIES PRIMARY LANGERHANS CELL HYSTIOCYTOSIS
Deniz Tuğcu
Hematol Transfus Cell Ther. 2023;45 Supl 3:S9-S10
Full text access
THROMBOSIS IN CHILDHOOD LEUKEMIA AND LYMPHOMA
Hasan Fatih Çakmaklı
Hematol Transfus Cell Ther. 2023;45 Supl 3:S10
Full text access
CANCER TREATMENT-RELATED CARDIOTOXICITY: OPTIMIZING HEART HEALTH FROM DIAGNOSIS TO LONG-TERM FOLLOW-UP
Melissa M. Hudson
Hematol Transfus Cell Ther. 2023;45 Supl 3:S10-S11
Full text access
TRANSFUSION IN PEDIATRIC ONCOLOGY
Suheyla Ocak
Hematol Transfus Cell Ther. 2023;45 Supl 3:S11
Full text access
APPROACH TO PAIN MANAGEMENT
Tuba Eren
Hematol Transfus Cell Ther. 2023;45 Supl 3:S11-S12
Full text access
Oral presentations
THE OUTCOME OF PERIPHERAL T-CELL LYMPHOMA PATIENTS FAILING FIRST-LINE THERAPY, FROM PROSPECTIVE COHORT OF T-CELL BRAZIL PROJECT
Carmino De Souza, Eliana Miranda, Jamila Tavares, Renata LR Baptista, Karin C Cecyn, Juliana Pereira, Marcelo Bellesso, Samuel S Medina, ... Carlos S Chiattone
Hematol Transfus Cell Ther. 2023;45 Supl 3:S13-S14
Full text access
IBRUTİNİB-OBİNUTUZUMAB COMBİNATİON THERAPY İN THE TREATMENT OF RELAPSED NODAL MARGİNAL ZONE LYMPHOMA: A CASE STUDY
Nuray Gül Açar, İbrahim Halil Açar, Birol Güvenç
Hematol Transfus Cell Ther. 2023;45 Supl 3:S14
Full text access
ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE VERSUS CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA (IKEMA): FINAL OVERALL SURVIVAL ANALYSIS
Ecenur Guder Arslan, Kwee Yong, Thomas Martın, Meletios Dımopoulos, Joseph Mıkhael, Marcelo Capra, Thierry Facon, Roman Hájek, ... Philippe Moreau
Hematol Transfus Cell Ther. 2023;45 Supl 3:S14-S15
Full text access
REAL-WORLD (RW) TREATMENT PATTERNS AND OUTCOMES IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) WITH AT LEAST ONE PRIOR THERAPY IN TURKEY
Ozgur Pektas, Prakash Navaratnam, Tanvi Rajput, Howard S. Frıedman, Ece Demırkır, Christina Tekle, Peggy Lın
Hematol Transfus Cell Ther. 2023;45 Supl 3:S15
Full text access
URETERAL AMYLOİDOSİS: A CASE REPORT OF SUCCESSFUL MANAGEMENT WİTH SURGERY, RADİATİON, AND CHEMOTHERAPY
İbrahim Halil Açar, Nuray Gül Açar, Birol Güvenç
Hematol Transfus Cell Ther. 2023;45 Supl 3:S15-S16
Full text access
THE ROLE OF ADAMTS13 ACTIVITY LEVELS ON DISEASE EXACERBATION OR RELAPSE IN PATIENTS WITH IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA: POST HOC ANALYSIS OF THE PHASE 3 HERCULES AND POST-HERCULES STUDIES
Johanna KREMER HOVINGA, Javier DE LA RUBIA, Katerina PAVENSKI, Ara METJIAN, Paul KNÖBL, Flora PEYVANDI, Spero CATALAND, Paul COPPO, ... Marie SCULLY
Hematol Transfus Cell Ther. 2023;45 Supl 3:S16
Full text access
EVALUATION OF VITAMIN D STATUS IN ADULT PATIENTS WITH IMMUNE THROMBOCYTOPENIA
Rafiye Ciftciler, Cevdet Yıldırımel, Ali Erdinç Çiftçiler, Esra Seçkin, Mehmet Dağlı
Hematol Transfus Cell Ther. 2023;45 Supl 3:S17
Full text access
CHANGES IN MUCOSA-ASSOCIATED INVARIANT T CELLS (MAIT), ASSOCIATED CYTOKINES, AND MR-1+ CELL NUMBER AND PHENOTYPE IN THE PERIPHERAL BLOOD OF PEDIATRIC ITP PATIENTS WITH AND WITHOUT ELTROMBOPAG THERAPY
Ahmet Eken, Metin Çil, Zehra Busra Azizoglu, Ramazan Üzen, Nazly Najat ASAAD, Sahin CALIK, Koray DORTERLER, Enes Mehmet Turkoglu, ... Ekrem Ünal
Hematol Transfus Cell Ther. 2023;45 Supl 3:S17
Full text access
LONG-TERM OUTCOMES OF ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSED/REFRACTORY HODGKIN AND NON-HODGKIN LYMPHOMA: MULTI-CENTER EXPERINCE FROM TURKEY
Ayse Uysal, Nur Soyer, Hakan Ozdogu, Hakan Goker, Olgu Erkin Cınar, Burak Devecı, Asu Fergun Yılmaz, Isık Kaygusuz Atagunduz, ... Filiz Vural
Hematol Transfus Cell Ther. 2023;45 Supl 3:S18
Full text access
OUTCOME OF APLASTIC ANEMIA ACCORDING TO DISEASE SEVERITY
Alfadil Haroon, Syed Osman Ahmed Ahmed, Hazzaa Alzahrani, Riad El Fakih, Ali Alahmari, Alfadel Alshaibani, Naeem Chaudhri, Fahad Almohareb, ... Mahmoud Aljurf
Hematol Transfus Cell Ther. 2023;45 Supl 3:S19-S20
Full text access
GLOBAL RESEARCH PATTERNS ON BLOOD DONOR DEFERRAL: AN ANALYSIS OF THEMES, TRENDS, AND INFLUENCE
Birol Güvenç, İbrahim Halil Açar, Şule Menziletoğu Yıldız
Hematol Transfus Cell Ther. 2023;45 Supl 3:S20
Full text access
UNUSUAL PRESENTATİON OF RHABDOMYOSARCOMA WİTH BONE MARROW INVOLVEMENT AND CERVİCAL MASS: A 17-YEAR-OLD FEMALE CASE REPORT
Nuray Gül Açar, İbrahim Halil Açar, Berksoy Şahin, Birol Güvenç
Hematol Transfus Cell Ther. 2023;45 Supl 3:S20-S21
Full text access
NEW MOLECULAR TARGETS IN CANCER CELL BIOENERGETIC PATHWAYS
Tyumin Ivan
Hematol Transfus Cell Ther. 2023;45 Supl 3:S21
Full text access
ASSESSMENT OF VITAMIN B12 AND HOMOCYSTEINE LEVELS IN PREGNANT WOMEN ADMITTED FOR DELIVERY AND CORD BLOOD SAMPLES OF THEIR NEWBORN BABIES: A MULTICENTER STUDY
Zeynep Yildiz Yildirmak, Dildar Bahar Genç, Alev Kural, Veli Mihmanli, Suleyman Salman, Keziban Doğan, Mehmet Ali Çiftçi, Nazli Doktur Efeoğlu, ... Ebru Kale
Hematol Transfus Cell Ther. 2023;45 Supl 3:S23
Full text access
A GHOSAL HEMATODIAPHYSEAL DYSPLASIA CASE; EXCELLENT RESPONSE TO NON-STEROIDAL ANTI-INFLAMATORY DRUG TREATMENT
Hasan Fatih Cakmaklı, Hatice Mutlu, Şule Altıner, Fatma Aydın, Talia Ilerı, Elif Ince, Mehmet Ertem
Hematol Transfus Cell Ther. 2023;45 Supl 3:S23-S24
Full text access
A NEXT-GENERATION SEQUENCING TEST FOR CONGENITAL NEUTROPENIA IN PEDIATRIC PATIENTS
Ayça Koca Yozgat, Fatma Burçin Kurtipek, Zeliha Güzelküçük, Dilek Kaçar, Turan Bayhan, Namık Yaşar Özbek, Neşe Yaralı
Hematol Transfus Cell Ther. 2023;45 Supl 3:S25
Full text access
BK-VIRUS INFECTIONS IN PEDIATRIC LEUKEMIA PATIENTS DURING LEUKEMIA TREATMENT
Dilek Kaçar, Zeliha Güzelküçük, Ayça Koca Yozgat, Melek Işık, Neşe Yaralı
Hematol Transfus Cell Ther. 2023;45 Supl 3:S25
Full text access
MOLECULAR CHARACTERISTICS AND TREATMENT RESPONSE TO COG ALL PROTOCOL IN CHILDREN; A 16-YEAR SINGLE-CENTER STUDY
Cengiz Canpolat, Bengisu Güner, Mohamed Dalla, Funda Çorapcıoğlu, Meltem Kilercik
Hematol Transfus Cell Ther. 2023;45 Supl 3:S26
Full text access
INVESTIGATION OF SALİVARY MIR-9 AND SERUM CIP2A LEVELS IN FANCONI ANEMIA PATIENTS AT HIGH RISK OF DEVELOPING ORAL SQUAMOUS CELL CARCINOMA
Zişan Asal Kılıç, Çetin Timur, Tülin Tiraje Celkan, Şahin Öğreden, Nevin Yalman
Hematol Transfus Cell Ther. 2023;45 Supl 3:S26
Full text access
BUSULFAN-CYCLOPHOSPHAMIDE OR TREOSULFAN-FLUDARABINE-THIOTEPA-BASED MYELOABLATIVE CONDITIONING FOR CHILDREN WITH THALASSEMIA MAJOR, SINGLE CENTRE EXPERIENCE
Nihan Bayram, Yontem Yaman, Isik Odaman Al, Kursat Ozdilli, Murat Elli, Sema Anak
Hematol Transfus Cell Ther. 2023;45 Supl 3:S27-S28
Full text access
EFFECT OF GRAFT VERSUS HOST DISEASE PROPHYLAXIS ON THE LEUKEMIA FREE SURVIVAL IN PEDIATRIC PATIENTS WHO HEMATOPOETIC STEM CELL TRANSPLANTED FOR LEUKEMIA
Özge Aylin Boran, İkbal Ok Bozkaya, Mehtap Olcar Kanbur, Özlem Arman Bilir, Namık Yaşar Özbek
Hematol Transfus Cell Ther. 2023;45 Supl 3:S28
Full text access
Loading more articles...
Idiomas
Hematology, Transfusion and Cell Therapy